Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • OSI PHARMACEUTICALS INC Analyst Recommendations

  • Analyst Consensus: OSIP

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 2.267 Buy 15
    30 Days Ago 2.267 Buy 15
    60 Days Ago 2.333 Buy 15
    90 Days Ago 2.333 Buy 15
    120 Days Ago 2.308 Buy 13

  • Analyst Ratings: OSIP

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    Barclays Capital — Equal Weight 10/05/2009 36.00
    RBC Capital Mkts Sector Perform Outperform 07/13/2009 38.00
    Deutsche Securities — Hold 06/24/2009 33.00
    Oppenheimer — Perform 06/18/2009 —
    Boenning & Scattergood — Neutral 06/16/2009 —
    Thomas Weisel Overweight Market Weight 06/01/2009 —
    RBC Capital Mkts — Sector Perform 05/27/2009 —
    Barclays Capital — Equal Weight 05/15/2009 33.00
    UBS — Buy 04/30/2009 46.00
    Barclays Capital — Equal Weight 02/20/2009 37.50
    Canaccord Adams — Buy 02/20/2009 47.00
    Leerink Swann — Outperform 02/20/2009 48.00
    Lazard Capital — Buy 12/05/2008 45.00
    Stanford Research — Buy 11/20/2008 52.00
    Cowen & Co — Neutral 11/18/2008 —
    Stanford Research Hold Buy 11/10/2008 52.00
    UBS — Buy 07/24/2008 58.00
    Lazard Capital — Buy 07/24/2008 58.00
    BMO Capital Markets — Outperform 03/13/2008 55.00
    Wachovia Mkt Perform Outperform 03/03/2008 —
    Collins Stewart — Buy 02/22/2008 69.00
    UBS — Buy 01/04/2008 57.00
    Lehman Brothers Overweight Equal-weight 01/03/2008 —
    Banc of America Sec — Buy 12/04/2007 65.00
    Lazard Capital — Buy 11/30/2007 50.00
    Collins Stewart Market Perform Buy 11/30/2007 —
    Lazard Capital — Buy 10/26/2007 43.00
    Stanford Research — Hold 10/11/2007 —
    Lehman Brothers Underweight Overweight 08/28/2007 —
    Wachovia Underperform Mkt Perform 08/23/2007 —
    Next